Variant report

Variant	nsv605350
Chromosome Location	chr6:167833634-167838940
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TCP10-3	chr6:167838864-167838906	ucscGeneNc_uc003qvy_1
2	lnc-TTLL2-2	chr6:167837702-167837948	NONHSAT116104

Extended variants
information (count: 208 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:208 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9364945	chr6:167833634-167833635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs533651077	chr6:167833636-167833637	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs548920226	chr6:167833645-167833646	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs531622475	chr6:167833667-167833668	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs567164488	chr6:167833702-167833703	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs577050292	chr6:167833726-167833727	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs556468943	chr6:167833743-167833744	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs577801677	chr6:167833761-167833762	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs538889670	chr6:167833793-167833794	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs57014784	chr6:167833797-167833798	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs572457333	chr6:167833798-167833799	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs112678538	chr6:167833810-167833811	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs76857802	chr6:167833869-167833870	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs576382250	chr6:167833886-167833887	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs541236219	chr6:167833892-167833893	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs562811028	chr6:167833897-167833898	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs148194886	chr6:167833923-167833924	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs9347223	chr6:167833935-167833936	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs560394947	chr6:167833940-167833941	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs150494003	chr6:167834013-167834014	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs539591936	chr6:167834104-167834105	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs548824705	chr6:167834106-167834107	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs567229517	chr6:167834108-167834109	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs4644019	chr6:167834203-167834204	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs550053778	chr6:167834227-167834228	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs571657137	chr6:167834240-167834241	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs71004148	chr6:167834252-167834253	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs538952332	chr6:167834304-167834305	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs553907992	chr6:167834306-167834307	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs190436884	chr6:167834351-167834352	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs144065669	chr6:167834372-167834373	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs111760803	chr6:167834380-167834381	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs576375563	chr6:167834397-167834398	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs386708614	chr6:167834402-167834403	Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs4544888	chr6:167834404-167834405	Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs577966722	chr6:167834410-167834411	Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs72578751	chr6:167834456-167834457	Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs560263674	chr6:167834478-167834479	Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs72578752	chr6:167834486-167834487	Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs542693285	chr6:167834512-167834513	Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs560862336	chr6:167834526-167834527	Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs113327954	chr6:167834560-167834561	Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs531207254	chr6:167834593-167834594	Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs183297089	chr6:167834607-167834608	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
45	rs564263122	chr6:167834627-167834628	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
46	rs570920788	chr6:167834658-167834659	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
47	rs142776831	chr6:167834667-167834668	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
48	rs151230045	chr6:167834677-167834678	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
49	rs368517372	chr6:167834748-167834749	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
50	rs536485046	chr6:167834760-167834761	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	19435819	CNVD
Developmental delay	21147756	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Epilepsy	22083797	CNVD
Myelofibrosis	22110671	CNVD
chordoma	19801981	CNVD
Myxofibrosarcoma	16751306	CNVD
Autism	17483303	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute myeloid leukemia	19651601	CNVD
Sudden cardiac death	19188705	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:86 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:167829600-167833800	Weak transcription	H1 Cell Line	embryonic stem cell
2	chr6:167829600-167834800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr6:167829600-167841400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr6:167829800-167842200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
5	chr6:167830400-167840200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr6:167830600-167836600	Weak transcription	HUES6 Cell Line	embryonic stem cell
7	chr6:167832400-167834200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr6:167833200-167834200	Enhancers	Fetal Intestine Small	intestine
9	chr6:167833400-167834400	Enhancers	Rectal Mucosa Donor 31	rectum
10	chr6:167833400-167834400	Enhancers	HepG2	liver
11	chr6:167833600-167833800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
12	chr6:167833600-167834000	Enhancers	Gastric	stomach
13	chr6:167833600-167834200	Enhancers	HUES64 Cell Line	embryonic stem cell
14	chr6:167833600-167834200	Enhancers	Fetal Intestine Large	intestine
15	chr6:167833600-167834200	Enhancers	Rectal Mucosa Donor 29	rectum
16	chr6:167833800-167834000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
17	chr6:167833800-167834000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr6:167833800-167834200	Enhancers	Sigmoid Colon	Sigmoid Colon
19	chr6:167833800-167834800	Enhancers	ES-I3 Cell Line	embryonic stem cell
20	chr6:167833800-167835000	Enhancers	H1 Cell Line	embryonic stem cell
21	chr6:167833800-167835200	Enhancers	Stomach Mucosa	stomach
22	chr6:167833800-167835400	Active TSS	Duodenum Mucosa	Duodenum
23	chr6:167834000-167839400	Weak transcription	Gastric	stomach
24	chr6:167834000-167846400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
25	chr6:167834200-167834400	Weak transcription	Rectal Mucosa Donor 29	rectum
26	chr6:167834200-167834600	Weak transcription	HUES64 Cell Line	embryonic stem cell
27	chr6:167834200-167834600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
28	chr6:167834200-167834600	Weak transcription	Sigmoid Colon	Sigmoid Colon
29	chr6:167834200-167834800	Flanking Active TSS	Fetal Intestine Large	intestine
30	chr6:167834200-167835000	Flanking Active TSS	Fetal Intestine Small	intestine
31	chr6:167834400-167834600	Enhancers	Colonic Mucosa	Colon
32	chr6:167834400-167834600	Genic enhancers	HepG2	liver
33	chr6:167834400-167834800	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
34	chr6:167834400-167835200	Active TSS	Rectal Mucosa Donor 29	rectum
35	chr6:167834600-167834800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
36	chr6:167834600-167834800	Flanking Active TSS	Colonic Mucosa	Colon
37	chr6:167834600-167834800	Enhancers	Sigmoid Colon	Sigmoid Colon
38	chr6:167834600-167835000	Transcr. at gene 5' and 3'	HepG2	liver
39	chr6:167834600-167835200	Enhancers	HUES64 Cell Line	embryonic stem cell
40	chr6:167834600-167835200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
41	chr6:167834600-167835200	Bivalent Enhancer	Placenta	Placenta
42	chr6:167834800-167835000	Enhancers	Lung	lung
43	chr6:167834800-167835200	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr6:167834800-167835400	Active TSS	Colonic Mucosa	Colon
45	chr6:167834800-167835400	ZNF genes & repeats	Fetal Intestine Large	intestine
46	chr6:167834800-167835400	Active TSS	Rectal Mucosa Donor 31	rectum
47	chr6:167834800-167839400	Weak transcription	Sigmoid Colon	Sigmoid Colon
48	chr6:167835000-167835400	Enhancers	Fetal Intestine Small	intestine
49	chr6:167835000-167835400	Flanking Active TSS	HepG2	liver
50	chr6:167835000-167839000	Weak transcription	Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links